These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22320997)

  • 21. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.
    Zhang W; Stabile LP; Keohavong P; Romkes M; Grandis JR; Traynor AM; Siegfried JM
    J Thorac Oncol; 2006 Sep; 1(7):635-47. PubMed ID: 17409930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long exposure of environmental tobacco smoke associated with activating EGFR mutations in never-smokers with non-small cell lung cancer.
    Kawaguchi T; Ando M; Kubo A; Takada M; Atagi S; Okishio K; Asami K; Matsumura A; Tsujino K; Ignatius OS; Sasaki H
    Clin Cancer Res; 2011 Jan; 17(1):39-45. PubMed ID: 21059816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetics of lung cancer in people who have never smoked.
    Subramanian J; Govindan R
    Lancet Oncol; 2008 Jul; 9(7):676-82. PubMed ID: 18598932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
    Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
    Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificities of lung adenocarcinoma in women who have never smoked.
    Mazières J; Rouquette I; Lepage B; Milia J; Brouchet L; Guibert N; Beau-Faller M; Validire P; Hofman P; Fouret P
    J Thorac Oncol; 2013 Jul; 8(7):923-9. PubMed ID: 23608817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure.
    Arrieta O; Campos-Parra AD; Zuloaga C; Avilés A; Sánchez-Reyes R; Manríquez ME; Covián-Molina E; Martínez-Barrera L; Meneses A; Cardona A; Borbolla-Escoboza JR
    J Thorac Oncol; 2012 Aug; 7(8):1228-34. PubMed ID: 22659961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGFR and erbB2 mutation status in Japanese lung cancer patients.
    Sasaki H; Shimizu S; Endo K; Takada M; Kawahara M; Tanaka H; Matsumura A; Iuchi K; Haneda H; Suzuki E; Kobayashi Y; Yano M; Fujii Y
    Int J Cancer; 2006 Jan; 118(1):180-4. PubMed ID: 16003726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.
    Kosaka T; Yatabe Y; Endoh H; Kuwano H; Takahashi T; Mitsudomi T
    Cancer Res; 2004 Dec; 64(24):8919-23. PubMed ID: 15604253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers.
    Krishnan VG; Ebert PJ; Ting JC; Lim E; Wong SS; Teo AS; Yue YG; Chua HH; Ma X; Loh GS; Lin Y; Tan JH; Yu K; Zhang S; Reinhard C; Tan DS; Peters BA; Lincoln SE; Ballinger DG; Laramie JM; Nilsen GB; Barber TD; Tan P; Hillmer AM; Ng PC
    Cancer Res; 2014 Nov; 74(21):6071-81. PubMed ID: 25189529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative detection of p53 mutations in plasma DNA from tobacco smokers.
    Hagiwara N; Mechanic LE; Trivers GE; Cawley HL; Taga M; Bowman ED; Kumamoto K; He P; Bernard M; Doja S; Miyashita M; Tajiri T; Sasajima K; Nomura T; Makino H; Takahashi K; Hussain SP; Harris CC
    Cancer Res; 2006 Aug; 66(16):8309-17. PubMed ID: 16912213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
    Subramanian J; Velcheti V; Gao F; Govindan R
    J Thorac Oncol; 2007 Sep; 2(9):827-30. PubMed ID: 17805060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma.
    Andujar P; Pairon JC; Renier A; Descatha A; Hysi I; Abd-Alsamad I; Billon-Galland MA; Blons H; Clin B; Danel C; Debrosse D; Galateau-Sallé F; Housset B; Laurent-Puig P; Le Pimpec-Barthes F; Letourneux M; Monnet I; Régnard JF; Validire P; Zucman-Rossi J; Jaurand MC; Jean D
    Mutagenesis; 2013 May; 28(3):323-31. PubMed ID: 23435014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. hOGG1 Ser326Cys polymorphism and G:C-to-T:A mutations: no evidence for a role in tobacco-related non small cell lung cancer.
    Hu YC; Ahrendt SA
    Int J Cancer; 2005 Apr; 114(3):387-93. PubMed ID: 15551330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis.
    Boyle JM; Tandberg DJ; Chino JP; D'Amico TA; Ready NE; Kelsey CR
    Cancer; 2015 Feb; 121(4):598-604. PubMed ID: 25283893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
    Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
    Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland.
    Rusin M; Butkiewicz D; Malusecka E; Zborek A; Harasim J; Czyzewski K; Bennett WP; Shields PG; Weston A; Welsh JA; Krzyzowska-Gruca S; Chorazy M; Harris CC
    Br J Cancer; 1999 Jul; 80(9):1445-52. PubMed ID: 10424749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers.
    Wang Y; Broderick P; Matakidou A; Eisen T; Houlston RS
    Carcinogenesis; 2010 Feb; 31(2):234-8. PubMed ID: 19955392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort.
    Scoccianti C; Vesin A; Martel G; Olivier M; Brambilla E; Timsit JF; Tavecchio L; Brambilla C; Field JK; Hainaut P;
    Eur Respir J; 2012 Jul; 40(1):177-84. PubMed ID: 22267755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.